Martin Doelberg

1.7k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

Martin Doelberg is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Martin Doelberg has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Martin Doelberg's work include Pulmonary Hypertension Research and Treatments (13 papers), Systemic Sclerosis and Related Diseases (7 papers) and Connective Tissue Growth Factor Research (4 papers). Martin Doelberg is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Systemic Sclerosis and Related Diseases (7 papers) and Connective Tissue Growth Factor Research (4 papers). Martin Doelberg collaborates with scholars based in Switzerland, Germany and United States. Martin Doelberg's co-authors include Ekkehard Grünig, Oliver Distler, Vallerie V. McLaughlin, Christopher P. Denton, Gerry Coghlan, D Rosenberg, Harbajan Chadha‐Boreham, Diana Bonderman, Janet Pope and Dinesh Khanna and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and European Heart Journal.

In The Last Decade

Martin Doelberg

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

2013 541 citations Gerry Coghlan, Christopher P. Denton et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Martin Doelberg

Since Specialization

Citations

This map shows the geographic impact of Martin Doelberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Doelberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Doelberg more than expected).

Fields of papers citing papers by Martin Doelberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Doelberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Doelberg. The network helps show where Martin Doelberg may publish in the future.

Co-authorship network of co-authors of Martin Doelberg

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Doelberg. A scholar is included among the top collaborators of Martin Doelberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Doelberg. Martin Doelberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension 2021 ·Journal of the American College of Cardiology ·Kelly Chin, Olivier Sitbon, Martin Doelberg, Jeremy Feldman, J. Simon R. Gibbs, Ekkehard Grünig, Marius M. Hoeper, Nicolas Martin, Stephen C. Mathai, Vallerie V. McLaughlin, Loı̈c Perchenet, David Poch, Rajan Saggar, Gérald Simonneau, Nazzareno Galiè	90
2	Initial Triple Oral Therapy in Pulmonary Arterial Hypertension (PAH): Extended Long-Term Outcome Data from TRITON 2021 ·The Journal of Heart and Lung Transplantation ·Vallerie V. McLaughlin, Kelly Chin, Martin Doelberg, Nazzareno Galiè, Marius M. Hoeper, Stephen C. Mathai, Loı̈c Perchenet, Gérald Simonneau, Olivier Sitbon, Nicolas Martin, J. Simon R. Gibbs	1
3	Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study 2020 ·European Heart Journal ·Nazzareno Galiè, Olivier Sitbon, Martin Doelberg, J. Simon R. Gibbs, Marius M. Hoeper, Nicolas Martin, Stephen C. Mathai, Vallerie V. McLaughlin, Loı̈c Perchenet, Gérald Simonneau, Kelly Chin	2
4	Efficacy and Safety of Initial Triple Oral Versus Initial Double Oral Combination Therapy in Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH): Results of the Randomized Controlled TRITON Study 2020 ·Kelly Chin, Olivier Sitbon, Martin Doelberg, (unknown), Marius M. Hoeper, Nicolas Martin, Stephen C. Mathai, Vallerie V. McLaughlin, Loı̈c Perchenet, Gérald Simonneau, Nazzareno Galiè	14
5	Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort 2020 ·European Respiratory Journal ·Yasmina Bauer, Simon de Bernard, Peter Hickey, (unknown), (unknown), Peter Cornelisse, Harbajan Chadha‐Boreham, Oliver Distler, D Rosenberg, Martin Doelberg, Sébastiên Roux, Oliver Nayler, Allan Lawrie	60
6	Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON 2020 ·Olivier Sitbon, Nazzareno Galiè, Martin Doelberg, J. Simon R. Gibbs, Marius M. Hoeper, (unknown), Stephen C. Mathai, Vallerie V. McLaughlin, Loı̈c Perchenet, Gérald Simonneau, Kelly Chin	0
7	Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis 2018 ·European Respiratory Journal ·Gerry Coghlan, Matthias Wolf, Oliver Distler, Christopher P. Denton, Martin Doelberg, Satenik Harutyunova, Alberto M. Marra, Nicola Benjamin, Christine Fischer, Ekkehard Grünig	72
8	Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort 2017 ·Annals of the Rheumatic Diseases ·Carina Mihai, (unknown), Rucsandra Dobrotă, Diana Bonderman, Harbajan Chadha‐Boreham, Gerry Coghlan, Christopher P. Denton, Martin Doelberg, Ekkehard Grünig, Dinesh Khanna, Vallerie V. McLaughlin, Ulf Müller‐Ladner, Janet Pope, D Rosenberg, James R. Seibold, Madelon C Vonk, Oliver Distler	21
9	Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study 2014 ·Arthritis Research & Therapy ·Scott Visovatti, Oliver Distler, Gerry Coghlan, Christopher P. Denton, Ekkehard Grünig, Diana Bonderman, Ulf Müller‐Ladner, Janet Pope, Madelon C Vonk, James R. Seibold, (unknown), Martin Doelberg, Harbajan Chadha‐Boreham, D Rosenberg, Vallerie V. McLaughlin, Dinesh Khanna	37
10	Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study breakdown → 2013 ·Annals of the Rheumatic Diseases ·Gerry Coghlan, Christopher P. Denton, Ekkehard Grünig, Diana Bonderman, Oliver Distler, Dinesh Khanna, Ulf Müller‐Ladner, Janet Pope, Madelon C Vonk, Martin Doelberg, Harbajan Chadha‐Boreham, Harald Heinzl, D Rosenberg, Vallerie V. McLaughlin, James R. Seibold	541
11	OP0036 An Evidence-Based Tool for Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The Detect Study 2013 ·Annals of the Rheumatic Diseases ·Christopher P. Denton, Gerry Coghlan, Ekkehard Grünig, Diana Bonderman, Oliver Distler, Dinesh Khanna, Ulf Müller‐Ladner, Janet Pope, Madelon C Vonk, Martin Doelberg, Harbajan Chadha‐Boreham, Harald Heinzl, D Rosenberg, Vallerie V. McLaughlin, James R. Seibold	7
12	An Evidence-Based Screening Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: The DETECT Study 2012 ·CHEST Journal ·Vallerie V. McLaughlin, Gerry Coghlan, Christopher P. Denton, Ekkehard Gruenig, Diana Bonderman, Oliver Distler, Dinesh Khanna, Ulf Müeller-Ladner, Janet Pope, Madelon C Vonk, Martin Doelberg, Harbajan Chadha‐Boreham, Harald Heinzl, D Rosenberg, James R. Seibold	2
13	Acute Hemodynamic Effects of Single‐Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS‐1 Study 2009 ·The Journal of Clinical Pharmacology ·Ekkehard Gruenig, Evangelos D. Michelakis, Jean‐Luc Vachiéry, Carmine Dario Vizza, F. Joachim Meyer, Martin Doelberg, Doris Bach, Jasper Dingemanse, Nazzareno Galiè	49
14	Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury 2003 ·Anesthesia & Analgesia ·Thomas A. Neff, Martin Doelberg, Cornelius Jungheinrich, (unknown), Donat R. Spahn, Reto Stocker	115
15	Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5 2001 ·Anesthesia & Analgesia ·Olivier Langeron, Martin Doelberg, (unknown), Françis Bonnet, Xavier Capdevila, Pierre Coriat	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact